-
People and CultureFuture of HealthcareInnovationReimagine MedicineScientific DiscoveriesWorking at NovartisNovartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
The roots of Novartis reach back more than 250 years, to the chemical and scientific traditions that helped shape modern healthcare. Thirty years after its creation, a legacy of discovery and curiosity continues to guide its pursuit of new possibilities for patients.
People and Culture -
DiscoveryCancerDrug DevelopmentDrug DiscoveryOncologyReimagine MedicinePushing the prostate cancer treatment frontier: Radioligand therapy and beyond
Radioligand therapy (RLT) has helped change what’s possible in prostate cancer treatment, but Novartis continues to work on the next wave of innovations to bring new options to patients.
Discovery -
People and CultureCareersLocal ImpactSocial CommitmentWorking at NovartisNovartis partners with Special Olympics World Winter Games Switzerland 2029
Novartis partners with the Special Olympics to support neuro‑inclusion and build environments where everyone belongs.
People and Culture -
People and CultureClinical ScienceWomen in ScienceWorking at NovartisDrug DiscoveryFull Circle: A Story of Growth, Purpose and Coming Home to Novartis
Polly Cooper, Clinical Development Function Head, UK
People and Culture -

New long term social impact and sustainability targets
Novartis has announced new long-term Social Impact & Sustainability (SI&S) targets and goals, reinforcing our commitment to go beyond breakthroughs to maximize the impact of our medicines to support inclusive, resilient healthcare systems worldwide.
-
Access to HealthcareGlobal Health PartnershipsCardiovascular DiseaseCancerAccess to HealthcareWorking with communities to close gaps in heart disease and cancer care
Our innovations matter only when they reach the people who need them. Yet millions live with heart disease or cancer without knowing it or have limited access to care – especially those in low-income, rural or other hard-to-reach communities.
Access to Healthcare -
Patient PerspectivesLiving With DiseasePatient VoicesCancerManaging Quality of Life with CML
How shared decision-making can support living well from the start with chronic myeloid leukemia
Patient Perspectives -
People and CultureCareersEmerging TechnologyInnovationWorking at NovartisBuilding the Future: Novartis Innovation Lab - AI, Game Studio, XR & Emerging Tech
The leaders behind the Novartis Innovation Lab share how they are leveraging emerging technologies to win for patients.
People and Culture -
From Our LabsBiomedical ResearchCancerDrug DiscoveryEmerging TechnologyOncologyBringing proteins together to take cancer apart
A Q&A with Jake Haling, Head of Oncology Drug Discovery in San Diego, on induced proximity and how it could open new paths to treat cancer.
From Our Labs -
People and CultureCareersWorking at NovartisDrug DevelopmentInnovationSupercharging R&D: How AI helps us to bring medicines to patients faster
Max leads AI innovation in pharmaceutical development at Novartis. His story reflects how cutting-edge technology is combined with human expertise for meaningful impact.
People and Culture -
People and CultureCareersTropical DiseasesWomen in ScienceNeuroscienceWorking at NovartisTurning personal experience into purpose-driven careers
What drives someone to dedicate their career to reimagining medicine? Three women at Novartis share their deeply personal and unique stories.
People and Culture -
DiscoveryTropical DiseasesDrug DiscoveryBreaking ground in Global Health
Manju Ujjini, Head of Lead Discovery for our Global Health Biomedical Research group, discusses what’s next for his team in drug discovery
Discovery
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 34
- › Next page